Skip to main content
International Journal of Environmental Research and Public Health logoLink to International Journal of Environmental Research and Public Health
. 2021 Feb 4;18(4):1471. doi: 10.3390/ijerph18041471

Benefits of Dog-Assisted Therapy in Patients with Dementia Residing in Aged Care Centers in Spain

Eva Vegue Parra 1, Jose Manuel Hernández Garre 2, Paloma Echevarría Pérez 1,*
Editors: Robbert Huijsman, Lucia Carboni
PMCID: PMC7914582  PMID: 33557254

Abstract

(1) Background: Currently, the scientific evidence on the benefits of assisted therapy with dogs in dementia is not clear. In this study, we want to evaluate such benefits through a randomized controlled clinical trial in multiple centers across the country. (2) Methods: The participants were people over 65 years old with dementia, residing in senior centers in Spain (n = 334). The experimental group underwent assisted therapy with dogs based on the Comprehensive Cognitive Activation Program in Dementia, for 8 months, with weekly sessions of 45 min. Data were collected at the commencement, middle, and end of the program, to evaluate the aspects using the Mini-Examination Cognitive, the modified Bartell Index, the Cornell Scale for Depression in Dementia and the Neuropsychiatric Inventory. (3) Results: The results show significant improvements in the experimental group versus the control group in the affective (T1 = p 0.000; T2 = p 0.000) and behavioral (T1 = p 0.005; T2 = p 0.000) aspects, with the affective aspect displaying greater progress in participants with additional depressive (p = 0.022) or anxiety (p = 0.000) disorders, shorter institutionalization periods (r = −0.222, p = 0.004), and those undergoing complementary psychotherapy (p = 0.033) or alternative therapy (p = 0.011). (4) Conclusions: Dog therapy is effective in improving the affective and behavioral aspects of institutionalized patients with dementia.

Keywords: dog-assisted therapy, care centers, dementia, neurocognitive disorder, Alzheimer’s

1. Introduction

The World Health Organization estimates that 47.5 million people worldwide suffer from dementia; this number is expected to increase year-by-year, with the principal cause being institutionalization of the elderly [1]. The Diagnostic and Statistical Manual of Mental Disorders (DSM) describes the main psychiatric disorders, including dementia, which has been renamed a neurocognitive disorder (NCD) and is characterized by a decline in at least one of the cognitive domains (attention, executive function, memory, learning, language, visuoperceptual and visuoconstructive functions, or social cognition). From a clinical perspective, NCD may be classified as minimal, mild, moderate, or severe according to their advancement and the manifestation of more serious symptoms [2].

The progress of an NCD can be accompanied by the appearance of psychological symptoms (hallucinations, delirium, depression, apathy or anxiety) and behavioral symptoms (agitation, inappropriate behaviors, wandering or resistance to care), which cause suffering to the patient and the persons close to them [3,4]. There are various drugs indicated for dementia (cholinesterase inhibitors and memantine) and others to treat psychological and behavioral symptoms associated with dementia (neuroleptics, antidepressants, analgesics, etc.), all of which have side effects [5]. There are several studies that relate comorbidity and polypharmacy in people with dementia [6]. Therefore, potentially beneficial non-pharmacological methods are increasingly sought. This is the case of dog-assisted therapies (DAT), which are discussed here.

Human–animal interaction has been studied since the mid-20th century, and currently animals may be incorporated into therapeutic, educational, or social programs for various purposes. Thus, we understand DAT as being structured, goal-oriented therapies that are used by healthcare professionals and intentionally incorporate dogs in health with the purpose of obtaining therapeutic benefits and improving health and well-being. DAT affords opportunities for motivational, educational, and recreational benefits to improve quality of life [7].

In recent years, several studies have been conducted on the effectiveness of DAT in older people with NCD. Improvements have been observed in psychiatric symptoms such as agitation, aggressiveness, anxiety, depression, or apathy [8,9,10,11,12,13,14,15,16], improvements in social interaction with increased prosocial behavior [9,11], improved quality of life [17,18,19,20], or preservation of functions such as alertness [21] or blood pressure [22]. There are several theories that attempt to explain the observed benefits of these interventions. Some of these theories emphasize the activation of basic psychological processes such as attention, perception, or motivation in the presence of the animal and their importance for the achievement of therapeutic objectives [23].

Reviews conducted for the purpose of comparing results found much variability in the studies, making them difficult to compare. In selecting studies, many small ones are excluded based on quality, with few remaining to be examined. Some studies concluded that the improvements observed are not significant [9,13,14,15,16,19]. Studies with significant results cannot be replicated. Reasons for this may be excessively small samples (65 participants being the largest), little detail in the protocols, or variability in them (some use weekly sessions, others semiweekly, and the duration also varies) or different design (some are controlled and randomized, others not). In their conclusions, they pointed out the need for studies with a larger sample, better design, and more detail in the protocols used [24,25,26].

To that effect, the aim of the present study was to evaluate the benefits that a DAT program could provide for the affective, behavioral, cognitive, and functional aspects of patients with NCDs residing in care centers for the elderly in different provinces of Spain, through the use of a protocol based on the stimulation of basic psychological processes that is detailed and homogeneous, as well as a larger sample.

2. Materials and Methods

2.1. Design

Based on systematic reviews, we believe that the problems of replication and extrapolation of the results of current studies come from the need to obtain larger samples, better design and more detail in the protocols used [24,25,26]. We consider it especially important to improve this to be able to conclude whether DAT are beneficial for patients with NCD. For that reason, we start from the following hypothesis: DAT provide significant improvements for patients with NCD in the affective, behavioral, functional, and cognitive areas.

An experimental randomized controlled clinical trial was designed to answer the question of whether the DAT program provides significant benefits in the affective, behavioral, cognitive, and functional aspects to participating residents with NCD.

2.2. Participants

The study involved 18 centers distributed over the following Spanish provinces: Barcelona (2), Valencia (1), Cuenca (2), Alicante (1), Granada (2), Jaén (2), Sevilla (2), Badajoz (1), Toledo (1), Madrid (2), La Coruña (2). After excluding residents with a history of animal allergies or phobias, participation was invited from those who met the following inclusion criteria:

- Aged over 65 years.

- Diagnosed with an NCD and an evident cognitive deterioration, with a Mini Mental State Examination (MMSE) score of less than 25.

- Signed informed consent.

The application of these criteria yielded a sample of 371 participants, comprising 277 women and 93 men, ultimately reduced to a total of 334 after participant losses, as shown in the flow diagram (Figure 1). The degree of NCD was taken from center-supplied data as well as the clinical histories. The sample was randomized into two groups: the experimental group, which received the DAT and the usual therapies offered by the center, and the control group, which received the center’s usual treatments but not the DAT. The participants were stratified in accordance with their degree of cognitive deterioration, gender, age, and other independent variables, in order to ensure the homogeneity of the groups.

Figure 1.

Figure 1

Participant flow chart.

The therapies that were carried out in the participating centers and that we classified as usual therapies are occupational therapy and physical therapy that took place every day, and to a lesser extent, psychology, socio-cultural animation, and complementary therapies that took place once or twice a week. None of the centers had had dog-assisted therapy for at least a year.

2.3. Procedure

The DAT was implemented progressively by the centers between September 2018 and January 2019, with each center starting as it progressed through the established steps. Each team was composed of a DAT technician and their therapy dog. The formation of the teams was homogeneous and specific to the intervention program.

The dogs were selected according to the following criteria: good health, high sociability, high impulse control, and high learning ability. They were then trained by their technicians on the specific exercises of the program (walking on a leash, handling, positions, maintenance, and skills) through a friendly methodology based on various techniques of learning by conditioning, both emotional and socially cognitive.

The training of the technicians was specific in the preparation of their dogs and in the work with elderly people with NCD, in addition to the preparation of the sessions to be carried out.

A health professional from each center was responsible for monitoring and evaluation throughout the program.

An ad hoc program was created and implemented in all participating centers, based on the recommendations of the Institute for Elderly and Social Services (IMSERSO), which advocates a comprehensive approach to address all basic psychological processes (motivation, emotion, perception, attention, language, memory, thought, and learning) [27,28]. The program consisted of weekly sessions of 45 min, conducted in groups of 10 people plus the dog and the DAT handler, over a period of 8 months. The first sessions implied the creation of a link with a gradual and positive introduction to the dog’s world. The following sessions consisted of working on the areas under study through direct interaction with the dog and a final phase of farewell. Table A1 lists the objectives of the program and some related exercises and Table A2 includes examples of sessions with different objectives.

The strategies used in the sessions according to the objectives to be worked on were the following:

- Affective area: caressing and brushing the dog on a table or chair, positive communication by the professional towards the dog and the participants, encouraging the expression of positive emotions and promoting interaction with the dog and the rest of the participants in the group.

- Behavioral area: promotion of sustained attention to the dog and to the activity the professional is conducting with the dog, varied activities within each session, proposing alternative behaviors related to the dog when unadaptive behaviors are detected, respect for personal space in each need, promotion of relaxation through petting and brushing the dog directly on the table or chair.

- Functional area: activities aimed at working the upper body, coordination and fine motor skills with the dog with a central element, through imitation, order requests, collaboration in sequences and games with the dog.

- Cognitive area: work on spatial and temporal orientation at the beginning and end of each session. Promotion of attention and concentration of the dog to facilitate its participation in the tasks. Work on reminiscence and memory stimulation related to animals from their past. Language and thought stimulation through word formation games, sayings or categorization with the dog as the central element of the activity (with puzzles, bibs, and specific toys with which the dog and the participants interact).

2.4. Instruments and Variables

Data collection was conducted in the beginning, at four months, and at eight months of intervention by occupational therapists or working psychologists from the participating centers. For the measurement of the four areas of study or dependent variables, the following scales were used (all widely used in the centers and studies consulted) [8,9,10,11,12,13,14,15,16,17,18,19,20,21,22]: for the cognitive area, the Mini-Cognitive State Examination (MEC-30) with a weighted kappa index of 0.637; a sensitivity of 89.8% and specificity of 75.1% [29]; for the functional area, the modified Barthel index (kappa between 0.47 and 1.00 with respect to the interobserver and between 0.84 and 0.97 for the intraobserver) [30]; for the effective area, the Cornell Scale of Depression in dementia (CSDD) (kappa between 0.61 and 0.84 and a total reliability of 0.93, internal consistency of 0.81) [31,32], and for the behavioral area, the Neuropsychiatric Disorders Inventory (NPI) with a Pearson’s correlation index of 0.879 for the severity scale and 0.92 for the stress scale [33]. In addition, the following independent sociodemographic variables were collected from the clinical records: sex, age, education (basic, middle and higher) and center, and the clinical data collected included: type of disorder additional to dementia (cardiovascular disease, depression, anxiety and diabetes), time of residence, and regular daily therapies (occupational therapy, physical therapy) and weekly complementary therapies (psychological, socio-cultural animation and alternative therapy: music therapy, work therapy and geronto-gymnastics). To avoid information bias, the double-blind technique was applied so that neither the professionals who collected the data nor the analyst knew the exposure group from the control group.

2.5. Ethics

The project was performed in accordance with the Helsinki Declaration and the UCAM Ethics Committee, which issued its approval (code CE031820). The staff at the centers provided verbal and written information about the study to the residents and their families and obtained informed consent.

The therapy dogs were prepared specifically for the purpose and met the national and provincial standards applying to animal welfare, health requirements, and the mental, social, and emotional well-being of the dogs [34].

2.6. Data Analysis

All the data were collated into an Excel database (Microsoft, Redmond, WA, USA), and analyzed using the IBM SPSS statistical software (IBM, Armond, NY, USA). It was confirmed that the observations were independent, that the samples obeyed a normal distribution, and that the variances were uniform per Kolmogorov–Smirnov analysis and Levene’s test.

The level of therapy effectiveness was measured in different centers simultaneously. The evolution of the four measurement scales was analyzed at each stage of the program using t-tests for related samples, and the scoring differences between the experimental and control groups were analyzed via t-tests for independent samples. Effectiveness was also analyzed in terms of the independent variables, with the experimental group showing progress in its scores on the significant aspects according to gender, illness, type of complementary therapy (Student’s t-test for independent samples), age, years of residence (Pearson’s correlation coefficient), educational level, and residential center (single-factor ANOVA and Tukey’s HSD).

3. Results

Table 1 sets out the frequency distribution of the different independent variables, giving average scores of 13.3 (+7) for the MMSE, 8.4 (+6.9) for the CSDD, 10.91 (+19.8) for the NPI, and 49.53 (+31.4) for the Barthel index.

Table 1.

Description of participants.

Characteristics (n = 334) %
Women 259 77.5
Men 75 22.5
Higher education 14 4.2
Intermediate education 13 3.9
Basic education 235 70.4
None 72 21.6
Alzheimer-type dementia 181 54.2
Senile-type dementia 141 42.2
Other dementias 12 3.6
Cardiovascular disease 147 44
Depression 68 20.4
Anxiety 36 10.8
Diabetes 4 1.2
OT 242 72.5
Physiotherapy 214 64.1
Psychotherapy 56 16.8
Mood improvement 91 27.2
Complementary therapies 29 8.7
Initial evaluation X¯ σ
MMSE 13.3 7
CSDD 8.14 6.9
NPI 10.91 19.8
Barthel 49.53 31.4

n: sample size %: percentage; OT: occupational therapy; X¯ mean; σ: standard deviation, MMSE: Mini-Mental State Examination; CSDD; Cornell Scale for Depression in Dementia; NPI: Neuropsychiatric Inventory.

Significant differences are observed in the evolution of the scores recorded for the four aspects under study, both for the experimental group and for the control group at four and eight months, but with different trends. While the affective (CSDD) and behavioral (NPI) aspects progressed positively for the experimental group and negatively for the control group, the cognitive (MMSE) and functional (Barthel) aspects show a negative progression in both groups (Table 2). The first columns correspond to the averages of the three moments (T0, T1 and T2), and the following correspond to the differences between moment 0 and 1 (T0–T1) and between moment 1 and 2 (T1–T2), to observe the progression.

Table 2.

Evolution of groups.

DAT n T0 T1 T0–T1 T1 T2 T1–T2
DV X¯
σ
X¯
σ
95% CI t p X¯
σ
X¯
σ
95%CI t p
CSDD Experimental 171 8.14 5.38 2.2 11.1 0 5.38 4.33 3.2 14.2 0
6.92 5.9 3.2 5.9 5.4 4.3
Control 163 8.14 8.88 −1.12 −3.99 0 8.88 9.34 −1.62 −5.6 0
6.91 7.1 0.38 7.1 7.1 −0.78
NPI Experimental 171 10.67 6.29 3.1 6.59 0 6.29 5.3 4 7.8 0
19.2 15.8 5.7 15.8 14.8 6.7
Control 163 11.32 12.03 −1.52 −1.69 0.092 12.03 12.9 −2.7 −3 0.003
20.5 21.1 0.12 21.1 22.2 −0.56
MMSE Experimental 171 13.54 13.18 −2 1.26 0.21 13.18 13.03 −0.1 1.6 0.107
7.05 7.8 0.93 7.8 7.8 1.1
Control 163 13.04 12.23 0.32 3.29 0.001 12.23 11.9 0.59 4.2 0
6.98 7.2 1.29 7.2 7.2 1.63
Modified Barthel Experimental 171 51.46 48.27 1.7 4.3 0 48.27 47.6 1.9 3.9 0
31.3 31.3 4.6 31.3 31.8 5.7
Control 163 47.49 44.69 1.25 3.56 0 44.69 43.7 2.06 4.4 0
31.4 32.1 4.36 32.1 32.1 5.47

DV: dependent variable; CSDD: Cornell Scale for Depression in Dementia; NPI: Neuropsychiatric Inventory; MMSE: Mini-Mental State Exam; DAT: dog-assisted therapy; n: sample size; T0: initial evaluation; T1: intermediate evaluation; T2: final evaluation; X¯: arithmetic mean σ: standard deviation; %: percentage; CI; confidence interval; t: test statistic; p: significance.

At the commencement of the program, no significant differences were observed between the experimental and control groups in the four aspects under study; however, at four and eight months, there was a significant improvement in the scores of the experimental group versus the control group in the affective (T1 = p 0.000; T2 = p 0.00) and behavioral (T1 = p 0.00 and T2 = p 0.005) aspects (Table 3).

Table 3.

Comparison between groups.

T DV DAT n σ 95% CI t p
X¯ Lower Upper
T0 CDSS Experimental 171 8.14 6.92 −1.48 1.49 0.07 0.995
Control 163 8.14 6.91
NPI Experimental 171 10.67 19.15 −4.91 3.62 −0.29 0.766
Control 163 11.32 20.49
MMSE Experimental 171 13.54 7.05 −1 2.01 0.66 0.51
Control 163 13.04 6.98
Barthel Experimental 171 51.46 31.32 −2.78 10.71 1.15 0.249
Control 163 47.49 31.36
T1 CDSS Experimental 171 5.38 5.97 −4.91 −2.09 −4.89 0
Control 163 8.88 7.09
NPI Experimental 171 6.29 15.83 −9.73 −1.72 −2.81 0.005
Control 163 12.03 21.09
MMSE Experimental 171 13.18 7.86 −0.67 2.58 1.15 0.25
Control 163 12.23 7.23
Barthel Experimental 171 48.27 31.32 −3.24 10.4 1.03 0.303
Control 163 44.69 32.1
T2 CDSS Experimental 171 4.34 5.36 −6.39 −3.61 −7.09 0
Control 163 9.34 7.41
NPI Experimental 171 5.3 14.84 −11.71 −3.6 −3.72 0
Control 163 12.96 22.21
MMSE Experimental 171 13.03 7.78 −0.51 2.71 1.34 0.18
Control 163 11.93 7.19
Barthel Experimental 171 47.64 31.75 −2.96 10.78 1.12 0.264
Control 163 43.73 32.11

T: time; CSDD: Cornell Scale for Depression in Dementia; NPI: Neuropsychiatric Inventory; MMSE: Mini-Mental State Exam; DV: dependent variable; DAT: dog-assisted therapy; n: sample size; T0: initial evaluation; T1: intermediate evaluation; T2: final evaluation; X¯: arithmetic mean σ: standard deviation; %: percentage; CI; confidence interval; t: test statistic; p: significance.

In the post hoc analysis, we compared the significant differences found in the affective and behavioral areas with the independent variables. The sociodemographic variables that were examined, such as sex (p = 0.448 for the affective area, p = 0.393 for the behavioral area), age (p = 0.873 for the affective area, p = 0.342 for the behavioral area), and level of studies were not significant. In addition, comparisons were made between the centers without finding significant differences. The significant differences found are reflected in Table 4. We carried out two types of analysis: the t-test for independent samples for contrast with respect to additional pathologies and psychology and complementary therapies, and the Pearson correlation test for contrast with respect to time of residence. The cross-correlation of the two significant aspects (affective and behavioral) with the independent variables shows greater progress in the affectivity scores of patients who have an additional pathology such as depression (p = 0.022) or anxiety (p = 0.00) or who are receiving complementary psychotherapy (p = 0.033) or alternative therapy (p = 0.011). Patients with a shorter period of institutionalization also show greater progress in affectivity scores (r = −0.222, p = 0.004) (Table 4).

Table 4.

CDSS versus disorders, therapies, and time of residence.

DV CSDD Average Progress T0–T2
IV n T0–T2 σ 95% CI t p
Lower Upper
Depressive disorder YES 32 −8.66 16.08 0.58 7.49 2.31 0.022
NO 139 −4.62 6.26
Anxiety disorder YES 15 −14.13 21.69 4.99 14.21 4.11 0
NO 156 −4.53 6.23
Psychotherapy YES 28 −3.97 3.68 −2.14 −0.09 −2.18 0.033
NO 143 −2.89 2.15
Complementary therapy YES 12 −6.25 3.55 0.61 4.68 2.57 0.011
NO 159 −3.6 3.43
Period of residence n X¯
CSDD
σ X¯
years
σ CP p
171 4.34 5.36 1.06 1.69 −0.222 0.004

IV: independent variable; DV: dependent variable; CSDD: Cornell Scale for Depression in Dementia; n: sample; X¯: arithmetic mean; T0: initial evaluation; T2: final evaluation; T0–T2: difference in scores at commencement and end of program; σ: standard deviation; %: percentage; CI: confidence interval t; test statistic; p: significance; YES: meets the IV criterion; NO: does not meet the IV criterion; CP: Pearson correlation.

4. Discussion

The data show that DAT in patients with NCD is effective for both the affective and the behavioral area, significantly improving scores over a control group that follows an inverse trend of progressive worsening. This improvement shows a dose-response association, and better results are observed with longer exposure time. In the cognitive and behavioral area, however, a worsening is observed both in the exposure group and in the control group, although the deterioration is less for the exposure group during the whole intervention for the cognitive area. In the same way, it is observed that the user profile that shows the best evolution in the scores of the affective area is the patient with additional disorders of a depressive or anxious nature, who receives psychological or complementary therapy and who has been institutionalized for less time.

If we compare our study with previous research and systematic reviews, we can point out:

- In line with the recommendations of previous studies [24,25,26], the sample was increased from 65 subjects to 334 [14], and the exposure time was similar to that of the longer-term study [19].

- Our results coincide in the significant improvement in the affective and behavioral areas with several studies in which significant progression were also evident [8,10,11,12,17,18]. These studies show significant improvements in SPCD, such as agitation and aggressiveness, which belong to the behavioral area, and depression, which belongs to the affective area. In all of them, the results are significant improvements; however, other studies point to improvement trends that were not significant [9,13,14,15,16,17,19,20]. Given the results obtained in our study, we understand that the diversity in the mentioned studies may be due to the small sample analyzed, since in all of them an improvement is observed. We can say that the assisted therapy with dogs is a good complement for the improvement in the SPCD.

- As for the lack of improvement in the cognitive and functional areas, our results also coincide with the conclusions of the systematic reviews [24,25,26], although in our case, a slight deterioration is observed over time.

In summary, it can be concluded that the best evidence in the affective and behavioral areas can have a positive influence at the psychosocial level and on the quality of life [17,18,19,20,21], which provides more data on the potential of these interventions as a complement to and support for the theories related to motivation, attention, social support, learning, and activation of the experimental system developed to date [23].

Although this study presents a larger sample than the previous ones, more extensive research is recommended to support the evidence. The protocol followed was based on that already studied by Gallardo Schall and Rivas Espinoza [8]. We used this protocol as a basis because one of the authors designed it and it turned out to be promising, though we adapted it to weekly sessions and the number of sessions was increased. We consider this study important, albeit with limitations: we did not consider whether the participants have had a dog before, although we know that in the sample there are participants who have had a dog before and others who have not. This may be something to consider in future research. Nevertheless, we consider that this study can be a starting point for future, more specific research since the results show, in a general way, that the protocol used is effective at an affective and behavioral level. We believe that it is useful to determine the areas sensitive to the intervention, the dose, or temporality of the intervention and the profile of the patient who benefits most from the protocol.

5. Conclusions

Based on the above findings, we conclude that assisted therapy with dogs has beneficial effects in people with institutionalized dementia at an affective and behavioral level. It can be useful to palliate affective and behavioral symptoms frequent in residents of senior centers if we incorporate it as a complement to the interventions already carried out in such centers.

Acknowledgments

We would like to thank the staff of the participating centers for their involvement in data collection and supervision of the entire program. To the professionals and dogs of Asgecan terapias for their dedication to the realization and conscientious completion of the program, especially to Joan Pau Aguado Muñoz who oversaw the coordination, communication and information to the centers during the whole process. To the managing entities of the participating centers for facilitating our research and for betting on assisted therapy with dogs, including it as a complement to their interventions: Mensajeros de la Paz, Grupo Sergesa, Grupo Orpea, Sanitas, Macrosad, Grupo Norte, Grupo Mutuam, Villamayor de Santiago City Council, Campos del Paraiso City Council, Les Boqueres Residence.

Appendix A

Table A1.

Objectives of the DAT program.

Aspect Target Session Dynamic
Cognitive Memory All Questions relating to the session
Language All Questions and answers
Thought All Introduction using drawings and actual materials
Recognition of faces, objects, numbers and letters All Use of drawings, photographs and actual materials
Perception All Sensory stimulation with direct interaction with the dog
Attention All With the dog as focus of attention
Orientation Question routine on topic
Affective Motivation All Using the dog as reinforcement
Increase in positive expressions All Using the handler as model and evoking positive memories
Social relations All With the dog as catalyzing agent
Increase in self-concept All With the satisfaction of obtaining the dog’s attention and cooperation
Behavioural Turn-taking All With the dog as a resource for turn-marking
Controlling frustration All Staying motivated about obtaining positive results with the dog
Participation All Offering various activities of participant interest with the dog
Functional Coordination All Performing exercises with the dog that require complex movements
Fine motor skills All Exercises requiring manipulation of different materials with the hands and fingers
Gross motor skills All Performing dog-accompanied exercises that require arm movement

The program consisted of 32 sessions of 45 min each, conducted weekly over eight months with groups of 10 participants.

Table A2.

Sample sessions.

SESSION 5 A Perfect Day (Empathy, Interaction, Communication, and Imagination)
MATERIAL Photos of the dog in different situations and the agenda of the day in the harness.
DEVELOPMENT The photos are handed out and commented on. Afterwards, all of us put them in the harness to make a perfect day justifying with the interests of the dog.
DAT TECHNICIAN Support in remembering things that the dog likes, stimulating interaction and communication between them, control and observation of the dog and its well-being.
DOG Support in the recognition of position pictures.
SESSION 15 Find the differences (attention and memory)
MATERIAL Velcro work harness, objects of various shapes and colors to stick.
DEVELOPMENT We put four things on the harness (a red ball, a drawing of a sun, a letter and a smiling face). We walk the dog around the room so that everyone memorizes the objects and disposition. Then we hide the dog and remove an object. We walk the dog again and ask them to tell us what the difference is. We make several rounds varying the difficulty depending on the cognitive level of the participants.
DAT TECHNICIAN Change the objects according to difficulty; encourage the participants to participate in the activity; position the dog according to the participant’s needs (the more deterioration, the closer); observe the dog and its well-being throughout the session.
DOG Walk on a leash; standing, sitting, and lying positions with 1-to-2-min stays.
When any sign of stress is detected in the dog, it will be offered water and a rest. We will encourage this observation by the participants with specific dog communication learning sessions in the beginning of the program. These breaks will be used to comment on the session or discuss what is interesting.

Author Contributions

Conceptualization, E.V.P.; methodology, E.V.P., J.M.H.G. and P.E.P.; software, J.M.H.G.; validation, J.M.H.G. and P.E.P.; formal analysis, J.M.H.G.; investigation, E.V.P.; resources, E.V.P.; data curation, E.V.P.; writing—original draft preparation, E.V.P.; writing—review and editing, J.M.H.G. and P.E.P.; visualization, E.V.P., J.M.H.G. and P.E.P.; supervision, J.M.H.G. and P.E.P.; project administration, P.E.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by UCAM Ethics Committee, which issued its approval (code CE031820). The staff at the centers provided verbal and written information about the study to the residents and their families and obtained the informed consent.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

Footnotes

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Martínez-Lage P., Martín-Carrasco M., Arrieta E., Rodrigo J., Formiga F. Map of Alzheimer’s disease and other dementias in Spain. MapEA Project. Rev. Esp. Geriatr. Gerontol. 2018;53:26–37. doi: 10.1016/j.regg.2017.07.006. [DOI] [PubMed] [Google Scholar]
  • 2.American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, (DSM-5®) 5th ed. American Psychiatric Pub; Washington, DC, USA: 2013. [Google Scholar]
  • 3.Romero A.P., Garrido S.G. The importance of behavioural and psychological symptoms in Alzheimer’s disease. Neurología. 2018;33:378–384. doi: 10.1016/j.nrleng.2016.02.026. [DOI] [Google Scholar]
  • 4.Cipriani G., Vedovello M., Nuti A., Di Fiorino M. Aggressive behavior in patients with dementia: Correlates and management. Geriatr. Gerontol. Int. 2011;11:408–413. doi: 10.1111/j.1447-0594.2011.00730.x. [DOI] [PubMed] [Google Scholar]
  • 5.Domínguez M.J.F., Gómez M.A.H., Barral A.G., Moneo M.J.G. Haciendo equilibrios entre los riesgos y beneficios del tratamiento farmacológico en demencia, dolor crónico y anticoagulación en personas mayores. Atención Primaria. 2018;50:39–50. doi: 10.1016/j.aprim.2018.09.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Clague F., Mercer S.W., McLean G., Reynish E., Guthrie B. Comorbidity and polypharmacy in people with dementia: Insights from a large, population-based cross-sectional analysis of primary care data. Age Ageing. 2017;46:33–39. doi: 10.1093/ageing/afw176. [DOI] [PubMed] [Google Scholar]
  • 7.IAHAIO International Association of Human-Animal Interaction Organizations. The IAHAIO Definitions for Animal Assisted Intervention and Animal Assisted Activity and Guidelines for Wellness of Animals Involved. [(accessed on 20 December 2020)];2013 Available online: http://www.iahaio.org/new/fileuploads/8000IAHAIO%20WHITE%20PAPER%20TASK%20FORCE%20-%20FINAL%20REPORT%20-%20070714.pdf.
  • 8.Schall P.A.G., Espinoza R.E.R. Terapia asistida con perros en pacientes con demencia y SPCD institucionalizados en centros residenciales de Toledo, España. [(accessed on 20 December 2020)];Inf. Psiquiátricas. 2015 220:113–126. Available online: http://informacionespsiquiatricas.com/informe220/files/assets/basic-html/index.html#1. [Google Scholar]
  • 9.Nordgren L., Engström G. Effects of dog-assisted intervention on behavioural and psychological symptoms of dementia: Lena Nordgren and Gabriella Engström present the results from a study that used dogs as an alternative or a complement to pharmacological treatments. Nurs. Older People. 2014;26:31–38. doi: 10.7748/nop2014.03.26.3.31.e517. [DOI] [PubMed] [Google Scholar]
  • 10.Travers C., Perkins J., Rand J., Bartlett H., Morton J. An evaluation of dog-assisted therapy for residents of aged care facilities with dementia. Anthrozoos. 2013;26:213–225. doi: 10.2752/175303713X13636846944169. [DOI] [Google Scholar]
  • 11.Pérez-Sáez E., Pérez-Redondo E., González-Ingelmo E. Effects of Dog-Assisted Therapy on Social Behaviors and Emotional Expressions: A Single-Case Experimental Design in 3 People With Dementia. J. Geriatr. Psychiatry Neurol. 2020;33:109–119. doi: 10.1177/0891988719868306. [DOI] [PubMed] [Google Scholar]
  • 12.Sellers D.M. The evaluation of an animal assisted therapy intervention for elders with dementia in long-term care. Act. Adapt. Aging. 2006;30:61–77. doi: 10.1300/J016v30n01_04. [DOI] [Google Scholar]
  • 13.Tournier I., Vives M.-F., Postal V. Animal-assisted intervention in dementia: Effects on neuropsychiatric symptoms and on caregivers’ distress perceptions. Swiss J. Psychol. 2017;76:51. doi: 10.1024/1421-0185/a000191. [DOI] [Google Scholar]
  • 14.Majić T., Gutzmann H., Heinz A., Lang U.E., Rapp M.A. Animal-assisted therapy and agitation and depression in nursing home residents with dementia: A matched case—control trial. Am. J. Geriatr. Psychiatry. 2013;21:1052–1059. doi: 10.1016/j.jagp.2013.03.004. [DOI] [PubMed] [Google Scholar]
  • 15.Mossello E., Ridolfi A., Mello A.M., Lorenzini G., Mugnai F., Piccini C., Barone D., Peruzzi A., Masotti G., Marchionni N. Animal-assisted activity and emotional status of patients with Alzheimer’s disease in day care. Int. Psychogeriatr. 2011;23:899–905. doi: 10.1017/S1041610211000226. [DOI] [PubMed] [Google Scholar]
  • 16.Motomura N., Yagi T., Ohyama H. Animal assisted therapy for people with dementia. Psychogeriatrics. 2004;4:40–42. doi: 10.1111/j.1479-8301.2004.00062.x. [DOI] [Google Scholar]
  • 17.Olsen C., Pedersen I., Bergland A., Enders-Slegers M.J., Patil G., Ihlebæk C. Effect of animal-assisted interventions on depression, agitation and quality of life in nursing home residents suffering from cognitive impairment or dementia: A cluster randomized controlled trial. Int. J. Geriatr. Psychiatry. 2016;31:1312–1321. doi: 10.1002/gps.4436. [DOI] [PubMed] [Google Scholar]
  • 18.Wesenberg S., Mueller C., Nestmann F., Holthoff-Detto V. Effects of an animal-assisted intervention on social behaviour, emotions, and behavioural and psychological symptoms in nursing home residents with dementia. Psychogeriatrics. 2019;19:219–227. doi: 10.1111/psyg.12385. [DOI] [PubMed] [Google Scholar]
  • 19.Berry A., Borgi M., Terranova L., Chiarotti F., Alleva E., Cirulli F. Developing effective animal-assisted intervention programs involving visiting dogs for institutionalized geriatric patients: A pilot study. Psychogeriatrics. 2012;12:143–150. doi: 10.1111/j.1479-8301.2011.00393.x. [DOI] [PubMed] [Google Scholar]
  • 20.Kårefjärd A., Nordgren L. Effects of dog-assisted intervention on quality of life in nursing home residents with dementia. Scand. J. Occup. Ther. 2019;26:433–440. doi: 10.1080/11038128.2018.1467486. [DOI] [PubMed] [Google Scholar]
  • 21.Briones M.Á., Pardo-García I., Escribano-Sotos F. Effectiveness of a Dog-Assisted Therapy Program to Enhance Quality of Life in Institutionalized Dementia Patients. Clin. Nurs. Res. 2019 doi: 10.1177/1054773819867250. [DOI] [PubMed] [Google Scholar]
  • 22.Friedmann E., Thomas S.A., Cook L.K., Tsai C.C., Picot S.J. A friendly dog as potential moderator of cardiovascular response to speech in older hypertensives. Anthrozoös. 2007;20:51–63. doi: 10.2752/089279307780216605. [DOI] [Google Scholar]
  • 23.Beetz A.M. Theories and possible processes of action in animal assisted interventions. Appl. Dev. Sci. 2017;21:139–149. doi: 10.1080/10888691.2016.1262263. [DOI] [Google Scholar]
  • 24.Zafra-Tanaka J.H., Pacheco-Barrios K., Tellez W.A., Taype-Rondan A. Effects of dog-assisted therapy in adults with dementia: A systematic review and meta-analysis. BMC Psychiatry. 2019;19:41. doi: 10.1186/s12888-018-2009-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Yakimicki M.L., Edwards N.E., Richards E., Beck A.M. Animal-assisted intervention and dementia: A systematic review. Clin. Nurs. Res. 2019;28:9–29. doi: 10.1177/1054773818756987. [DOI] [PubMed] [Google Scholar]
  • 26.Lundqvist M., Carlsson P., Sjödahl R., Theodorsson E., Levin L.Å. Patient benefit of dog-assisted interventions in health care: A systematic review. BMC Complement. Altern. Med. 2017;17:358. doi: 10.1186/s12906-017-1844-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.García M., Carro J. IMSERSO; Madrid, Spain: 2011. [(accessed on 20 December 2020)]. Comprehensive Cognitive Activation Programme in Dementia (CCAPD). Centro de Referencia Estatal de Atención a Personas con Enfermedad de Alzheimer. Available online: http://www.crealzheimer.es/InterPresent1/groups/imserso/documents/binario/guia_pacid_web.pdf. (In Spanish) [Google Scholar]
  • 28.Rey B., Muñoz J., Sánchez A.M. Andavira Editor; La Coruna, Spain: 2014. [(accessed on 20 December 2020)]. Manual Para Implementar las Intervenciones Asistidas con Perros en el Ámbito de la Demencia Tipo Alzheimer y Otras Demencias [Manual to Implement Assistance with Dogs in the Field of Alzheimer-Type Dementia and Other Dementia] Available online: http://www.andavira.com/ebooks/manual_intervenciones_perros_demencia/files/assets/common/downloads/publication.pdf. (In Spanish) [Google Scholar]
  • 29.Llamas-Velasco S., Llorente-Ayuso L., Contador I., Bermejo-Pareja F. Versiones en Español del Minimental State Examination (MMSE). Cuestiones Para su uso en la Práctica Clínica. [(accessed on 20 December 2020)];Rev. Neurol. 2015 61:363–371. doi: 10.33588/rn.6108.2015107. Available online: https://www.researchgate.net/profile/Sara_Velasco2/publication/283842742_Spanish_versions_of_the_Minimental_State_Examination_MMSE_Questions_for_their_use_in_clinical_practice/links/565311fd08ae1ef92975ad01.pdf. (In Spanish) [DOI] [PubMed] [Google Scholar]
  • 30.Bernaola-Sagardui I. Validation of the Barthel Index in the Spanish population. Enferm. Clínica. 2018;28:210–211. doi: 10.1016/j.enfcli.2017.12.001. [DOI] [PubMed] [Google Scholar]
  • 31.Alexopoulos G.S., Abrams R.C., Young R.C., Shamoian C.A. Cornell Scale for Depression in Dementia. Biol. Psychiatry. 1988;23:271–284. doi: 10.1016/0006-3223(88)90038-8. [DOI] [PubMed] [Google Scholar]
  • 32.Ruano T.F., Jentoft A.J.C., Montalvo J.I.G., Soto A.L., Soler P.A. Herramientas de valoración geriátrica en Servicios de Geriatría españoles [Geriatric assessment tools in Spanish Geriatric Departments] Rev. Esp. Geriatr. Gerontol. 2014;49:235–242. doi: 10.1016/j.regg.2014.05.002. [DOI] [PubMed] [Google Scholar]
  • 33.Baquero M., Martín N. Depressive symptoms in neurodegenerative diseases. World J. Clin. Cases WJCC. 2015;3:682. doi: 10.12998/wjcc.v3.i8.682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Glenk L.M. Current perspectives on therapy dog welfare in animal-assisted interventions. Animals. 2017;7:7. doi: 10.3390/ani7020007. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Not applicable.


Articles from International Journal of Environmental Research and Public Health are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES